News

CEO views

The UK has the chance to lead the way in synbio. We must grasp it.

An article on synbio in the Summer 2023 issue of Science in Parliament magazine. Authored by our founder and CEO Mark Kotter.

17.07.2023

Published by Science in Parliament

An article on synbio in the Summer 2023 issue of Science in Parliament magazine. Authored by our founder and CEO Mark Kotter.

Published by Science in Parliament

Read now

CEO views

Industry responds to UK science strategy launch

Mark Kotter shares his thoughts in Labiotech on the importance of government support in enabling the UK to become a leading scienc...

18.05.2023

Published by Labiotech.eu

Read now

CEO views

Synbio and the opportunity within the UK’s innovation landscape

Mark Kotter, CEO shares his thoughts on Synbio and how the UK can support and expand this sector and become a powerhouse of scienc...

09.03.2023

Published by bit.bio

Read now

CEO views

Key opinions - biotech in 2023: reasons for optimism

Our CEO gives his take on what's in store for the biotech industry in 2023 as part of this forward looking feature.

16.01.2023

Published by Labiotech.eu

Read now

CEO views

The USA is seeing huge growth in synbio. UK mustn't miss out.

America is seeing huge growth in Synthetic Biology – the UK must ensure it doesn’t miss out.

25.07.2021

Published by Science in Parliament

Read now

Related pages